Intuitive Surgical Total Change in Assets/Liabilities 2010-2025 | ISRG
Intuitive Surgical annual/quarterly total change in assets/liabilities history and growth rate from 2010 to 2025. Total change in assets/liabilities can be defined as the sum of all line items in the Asset/Liability section of the Cash Flows Statement
- Intuitive Surgical total change in assets/liabilities for the quarter ending March 31, 2025 was $-0.439B, a 18.65% decline year-over-year.
- Intuitive Surgical total change in assets/liabilities for the twelve months ending March 31, 2025 was $-2.830B, a 49.45% increase year-over-year.
- Intuitive Surgical annual total change in assets/liabilities for 2024 was $-0.919B, a 18.22% increase from 2023.
- Intuitive Surgical annual total change in assets/liabilities for 2023 was $-0.778B, a 25.6% increase from 2022.
- Intuitive Surgical annual total change in assets/liabilities for 2022 was $-0.619B, a 68.19% increase from 2021.
| Intuitive Surgical Annual Total Change in Assets/Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $-919 |
| 2023 | $-778 |
| 2022 | $-619 |
| 2021 | $-368 |
| 2020 | $-273 |
| 2019 | $-322 |
| 2018 | $-384 |
| 2017 | $73 |
| 2016 | $-18 |
| 2015 | $-93 |
| 2014 | $14 |
| 2013 | $-22 |
| 2012 | $-66 |
| 2011 | $-20 |
| 2010 | $17 |
| 2009 | $38 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $202.843B | $8.352B |
| Intuitive Surgical Inc designs, manufactures and markets the da Vinci surgical system and related instruments and accessories, which is an advanced robot-assisted surgical system. The surgical system comprises a surgeon's console, patient-side cart, 3-D vision system, da Vinci Skills Simulator and Firefly Fluorescence Imaging. Intuitive Surgical's robot-based da Vinci surgical system enables minimally-invasive surgery that reduces the trauma associated with open surgery. The company also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures.?Additionally, the company sells various accessories comprising sterile drapes and vision products and other items that facilitate use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. The company operates through three segments: Instruments and Accessories, Systems and Services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $153.281B | 18.54 |
| Edwards Lifesciences (EW) | United States | $45.022B | 29.52 |
| Alcon (ALC) | Switzerland | $43.031B | 29.08 |
| IDEXX Laboratories (IDXX) | United States | $40.969B | 47.08 |
| DexCom (DXCM) | United States | $33.925B | 52.44 |
| IQVIA Holdings (IQV) | United States | $24.535B | 13.74 |
| Mettler-Toledo (MTD) | United States | $23.231B | 27.63 |
| STERIS (STE) | Ireland | $22.352B | 24.65 |
| Waters (WAT) | United States | $20.553B | 29.00 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.219B | 0.00 |
| Hologic (HOLX) | United States | $12.337B | 13.40 |
| Penumbra (PEN) | United States | $11.191B | 87.83 |
| Sysmex ADR (SSMXY) | Japan | $10.965B | 31.11 |
| Masimo (MASI) | United States | $8.304B | 30.63 |
| Globus Medical (GMED) | United States | $8.001B | 18.76 |
| Teleflex (TFX) | United States | $5.535B | 9.14 |
| Glaukos (GKOS) | United States | $5.232B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.173B | 21.87 |
| TransMedics (TMDX) | United States | $4.139B | 89.97 |
| PROCEPT BioRobotics (PRCT) | United States | $3.030B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.375B | 14.14 |
| Veracyte (VCYT) | United States | $2.231B | 31.31 |
| Nihon Kohden (NHNKY) | Japan | $2.050B | 23.51 |
| Elekta AB (EKTAY) | Sweden | $2.021B | 18.17 |
| Alphatec Holdings (ATEC) | United States | $1.862B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.522B | 0.00 |
| Artivion (AORT) | United States | $1.238B | 115.92 |
| Pulse Biosciences (PLSE) | United States | $1.097B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.004B | 5.34 |
| OPKO Health (OPK) | United States | $0.999B | 0.00 |
| SiBone (SIBN) | United States | $0.799B | 0.00 |
| IRadimed (IRMD) | United States | $0.660B | 33.49 |
| Mesa Laboratories (MLAB) | United States | $0.653B | 14.26 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.562B | 8.74 |
| Beta Bionics (BBNX) | United States | $0.557B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.555B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.539B | 0.00 |
| AxoGen (AXGN) | United States | $0.538B | 0.00 |
| RxSight (RXST) | United States | $0.538B | 0.00 |
| NeuroPace (NPCE) | United States | $0.512B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.467B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.423B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.377B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.363B | 9.66 |
| ClearPoint Neuro (CLPT) | United States | $0.348B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.330B | 0.00 |
| Neuronetics (STIM) | United States | $0.283B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.223B | 13.49 |
| Alpha Tau Medical (DRTS) | Israel | $0.199B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.170B | 0.00 |
| LENSAR (LNSR) | United States | $0.167B | 0.00 |
| Accuray (ARAY) | United States | $0.164B | 0.00 |
| Inogen (INGN) | United States | $0.158B | 0.00 |
| 908 Devices (MASS) | United States | $0.155B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.148B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.139B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.138B | 0.00 |
| CVRx (CVRX) | United States | $0.138B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.133B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.130B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.088B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.085B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.080B | 12.05 |
| InspireMD (NSPR) | Israel | $0.072B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.066B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.064B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.057B | 0.00 |
| Hyperfine (HYPR) | United States | $0.048B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.91 |